Incyte Corporation INCY
Incyte Corporation is a global biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. The company primarily develops and markets innovative medicines in oncology and inflammation/autoimmunity, with a strong portfolio of both commercialized products and a robust pipeline of drug candidates. Incyte serves patients worldwide through its own commercial operations in the United States and strategic partnerships for international markets. Its business model combines internal research and development with selective acquisitions and collaborations to advance novel treatments for serious unmet medical needs.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.